<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-101816" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Histology, Osteoprogenitor Cells</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Nahian</surname>
            <given-names>Ahmed</given-names>
          </name>
          <aff>California Baptist University - Lake Erie College of Osteopathic Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Davis</surname>
            <given-names>Donald D.</given-names>
          </name>
          <aff>Wellstar Atlanta Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ahmed Nahian declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Donald Davis declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>29</day>
          <month>12</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-101816.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Osteoprogenitor cells, also known as osteogenic cells, are stem cells in the bone that play a prodigal role in bone repair and growth (see <bold>Image.</bold> Cells in the Bone).<xref ref-type="bibr" rid="article-101816.r1">[1]</xref>&#x000a0;These cells are the precursors to the more specialized bone cells (osteocytes and osteoblasts) and reside in the bone marrow. Osteoprogenitor cells originate from infant mesenchymal cells and turn into spindle cells at the surface of matured bones. In developing bones, they appear more frequently and activate multifunctional stages to remodel the bones. The body loses the ability to synthesize or utilize more osteoprogenitor cells with age. Dysfunction of osteoprogenitor cells may delay ossification and lead to a spectrum of diseases such as dwarfism&#x000a0;and Kashin-Beck disease.<xref ref-type="bibr" rid="article-101816.r2">[2]</xref></p>
      </sec>
      <sec id="article-101816.s2" sec-type="Structure">
        <title>Structure</title>
        <p>Osteoprogenitor cells are often referred to as preosteoblasts.&#x000a0;They can be present within the endosteum, the cellular layer of the periosteum, and the lining of the osteogenic cells. Osteoprogenitor cells exist as flattened spindle-shaped structures in matured bones that no longer display active bone remodeling or formation. They attach to the bone surface and&#x000a0;are called inactive osteoblasts during this period. In maturing bones, however, these cells appear in their largest form. During fetal development or high turnover periods&#x000a0;in adult osteogenesis, numerous osteoprogenitor cells function to give rise to osteoblasts. These structures display plump oval nuclei and emboldened abundant spindle-shaped cytoplasm at this stage, later converting to characteristic cuboidal active osteoblasts.<xref ref-type="bibr" rid="article-101816.r3">[3]</xref><xref ref-type="bibr" rid="article-101816.r4">[4]</xref></p>
      </sec>
      <sec id="article-101816.s3" sec-type="Function">
        <title>Function</title>
        <p>Osteoprogenitors can self-proliferate and self-renew. They participate in osteogenic differentiation and play a role in regulating angiogenesis.<xref ref-type="bibr" rid="article-101816.r5">[5]</xref> Osteoprogenitor cells can differentiate into osteoblasts through mitotic division or by dividing into&#x000a0;2 stem cells via a highly regulated mechanism,&#x000a0;which remains static during the proliferation process. After DNA synthesis and cell expansion, the cell retains its original genetic information. The endocrine system and local factors (growth factors and cytokines) mainly regulate osteogenesis.</p>
        <p>Neuropeptide Y is a potent regulator of osteogenesis, and recent studies have confirmed that osteoprogenitor cells originating from hypothalamic Y2-/- mice have enhanced osteogenic activities.<xref ref-type="bibr" rid="article-101816.r6">[6]</xref>&#x000a0;Proline-rich tyrosine kinase 2 supposedly regulates the differentiation of early osteoprogenitors, and proline-rich tyrosine kinase 2 inhibitors promote osteogenesis and could act as a treatment for osteoporosis.<xref ref-type="bibr" rid="article-101816.r7">[7]</xref>&#x000a0;Osteoprogenitor cells also reside in the perichondrium. These osteoprogenitors hyper-regulate bone morphogenetic proteins during differentiation into mature osteoblasts and are responsible for the production of bone matrix.<xref ref-type="bibr" rid="article-101816.r8">[8]</xref></p>
      </sec>
      <sec id="article-101816.s4" sec-type="Tissue Preparation">
        <title>Tissue Preparation</title>
        <p>Bone marrow stromal cells (BMSCs) yield testable osteoprogenitors. The cell samples are diluted with phosphate-buffered saline (PBS) at a ratio of 1:3, and then nucleated cells are isolated with a density gradient solution. Preparatory phase complete medium (CM) consists of&#x000a0; 0.1 mmol/L nonessential amino acids, alpha-MEM with 10% fetal bovine serum, 4.5 mg/mL d-glucose, 1 mmol/L sodium pyruvate, 100 U/mL penicillin, 100 mmol/L HEPES buffer, 100 &#x003bc;g/mL streptomycin, and 0.29 mg/mL l-glutamine.<xref ref-type="bibr" rid="article-101816.r9">[9]</xref>&#x000a0;</p>
        <p>The collected nucleated cells are plated at 100,000 cells/cm^2 density in supplemented CM. The CM supplement requires an additional 5 ng/mL fibroblast growth factor-2 (GF2) and 10 nmol/L dexamethasones; both elements proliferate osteogenic commitment of bone marrow stromal cells. The supplemental process undergoes humidification at 37 degrees C in a 5% CO2 incubator.<xref ref-type="bibr" rid="article-101816.r10">[10]</xref></p>
      </sec>
      <sec id="article-101816.s5" sec-type="Histochemistry and Cytochemistry">
        <title>Histochemistry and Cytochemistry</title>
        <p>Several research groups have studied the development of osteoprogenitor cells. A study suggests that the perichondrial Thy-1&#x02013;positive cells demonstrate potential osteogenic activity and participate in osteoblast formation during endochondral ossification. Another study shows intense alkaline phosphatase activity&#x000a0;2 weeks after osteogenic induction and the presence of mineralized nodules. The expression of bone sialoprotein, dentin matrix protein-1, and osteocalcin increases due to ALP proliferation. As confirmed by flow cytometry, 55 to 65% of cells display the cell-surface markers Sca1+ and Thy1+ in vitro expansion for an alpha-SMA-GFP positive population. The alpha-SMA&#x02013;GFP-positive population also exhibits higher proliferative and osteogenic probabilities compared to an alpha-SMA&#x02013;GFP-negative population.<xref ref-type="bibr" rid="article-101816.r8">[8]</xref><xref ref-type="bibr" rid="article-101816.r11">[11]</xref></p>
      </sec>
      <sec id="article-101816.s6" sec-type="Microscopy, Light&#x0000d;&#x0000a;">
        <title>Microscopy, Light
</title>
        <p>Final visualization of osteoprogenitor cells under the microscope involves a delicate preparation phase: the explants are fixed in 4% buffered formalin for&#x000a0;1 whole day, and samples are decalcified with 0.5 mol/L ethylenediaminetetraacetic acid (pH 8) for 7 to 10 days. The samples are deposited in paraffin, and the cross-sections of the samples are prepared with 5 um thickness at&#x000a0;3 different strata.<xref ref-type="bibr" rid="article-101816.r12">[12]</xref></p>
        <p>The samples are stained with hematoxylin/eosin and Masson/Trichrome, and both a qualitative exam for the presence of bone tissue and a quantitative exam by computerized bone histomorphometry is conducted. For each hematoxylin/eosin-stained cross-section, 3 or 4 images (adequate to fill the construct cross-sections) are required to calculate the bone tissue area and available area for tissue ingrowth (net implant area - undegraded scaffold area) by digital imaging analysis. Under the scanning electron microscopy (SEM) visuals, the red color in the slides indicates that the Masson/Trichrome stains indicate lamellar and remodeled bone, while the blue color shows freshly deposited and immature bone.<xref ref-type="bibr" rid="article-101816.r9">[9]</xref></p>
      </sec>
      <sec id="article-101816.s7" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Bone tumors are formed within osteoprogenitor or stromal cell lineage during Paget disease (PD), which likely derive from genetic alterations related to familial Paget&#x02019;s disease. During Paget&#x02019;s disease, the endosteal surface undergoes active remodeling, and abnormal osteoclasts bearing nuclear inclusions occur. The fibrotic tissues in bone biopsies from PD patients are considered to be made of surplus elongated, sophisticatedly branched stromal cells that display high alkaline phosphatase levels; these cells are similar to the pre-osteogenic stromal cells located within the normal bone marrow.<xref ref-type="bibr" rid="article-101816.r13">[13]</xref></p>
        <p>Early and full-blown pagetic lesions show dynamic transformations in the arrangement, number, and function of stromal cells within endosteal/medullary tissue. An excessive amount of bone marrow osteoprogenitor cells in pagetic lesion areas verify earlier data on static and dynamic histomorphometry in patients with Paget&#x02019;s disease. Previous data revealed that the rate of osteogenesis increases during Paget disease, but research has confirmed that there is also a surge in the birthrate of osteoblasts.<xref ref-type="bibr" rid="article-101816.r14">[14]</xref></p>
        <p>The quality of the new bones depends on nature and hypermineralization. Most stromal/osteoblastic abnormalities result from bone mass increment, characterized by denser and thicker trabecular structures. Another characteristic is compromised mechanical integrity caused by poor architectural organization and transformations within the mineralized matrix material.<xref ref-type="bibr" rid="article-101816.r15">[15]</xref></p>
      </sec>
      <sec id="article-101816.s8" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Mesenchymal stem cells (MSCs) collected from adipose and bone marrow tissue hold therapeutic value for various bone disease treatments. Current studies demonstrate the benefit of bone grafts based on combinations of MSC, biomimetic scaffolds, and growth factor delivery, which showed an increased osteogenic regeneration rate with minimal side effects. The specific mechanisms of cellular signaling in bone remodeling are essential in understanding the incorporation of newer effective treatment methods for numerous bone diseases.<xref ref-type="bibr" rid="article-101816.r16">[16]</xref></p>
        <p>Various transplant therapies involving osteogenic autologous bone grafts are less frequently used; patient-specific cell therapies involving autologous BM-MNCs (bone marrow mononuclear cells) composed of stem cells, monocytes, lymphocytes, and dendritic cells are rising in popularity for bone pathology treatments. All patients suffering from long-bone pseudoarthrosis attained full bone consolidation when treated with autologous BM-MNCs and allogeneic cancellous bone grafts. Bone marrow aspirate utilized during osteonecrosis treatment via minimally invasive decompression of the femoral head decreased disease progress and yielded overall pain and symptom relief. Bone marrow concentrated injections lead to better osteogenic unions, resulting in complete recovery in post-operative achondroplastic dwarf patients within 2&#x000a0;to 10 months after femoral lightning surgeries. Intravenous BMC injections, mixed with iloprost, proliferate fracture healing in patients with avascular necrosis. Patients receiving Intra-articular BMNc displayed better chewing and maximum interincisal opening with integral pain relief.<xref ref-type="bibr" rid="article-101816.r17">[17]</xref><xref ref-type="bibr" rid="article-101816.r16">[16]</xref></p>
      </sec>
      <sec id="article-101816.s9">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=101816&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=101816">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/101816/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=101816">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-101816.s10">
        <fig id="article-101816.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Cells in the Bone. The figure depicts the types of cells in the bone: osteoprogenitor cells, osteoblasts, osteocytes, and osteoclasts. Contributed by C Rowe</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="osteoprogenitor__cells" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-101816.s11">
        <title>References</title>
        <ref id="article-101816.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Friedenstein</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Chailakhyan</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Gerasimov</surname>
                <given-names>UV</given-names>
              </name>
            </person-group>
            <article-title>Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers.</article-title>
            <source>Cell Tissue Kinet</source>
            <year>1987</year>
            <month>May</month>
            <volume>20</volume>
            <issue>3</issue>
            <fpage>263</fpage>
            <page-range>263-72</page-range>
            <pub-id pub-id-type="pmid">3690622</pub-id>
          </element-citation>
        </ref>
        <ref id="article-101816.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ren</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Foulad</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tiffany</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Dewey</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Bischoff</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Reid</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Yamaguchi</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Harley</surname>
                <given-names>BAC</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Osteoprotegerin reduces osteoclast resorption activity without affecting osteogenesis on nanoparticulate mineralized collagen scaffolds.</article-title>
            <source>Sci Adv</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>5</volume>
            <issue>6</issue>
            <fpage>eaaw4991</fpage>
            <pub-id pub-id-type="pmid">31206025</pub-id>
          </element-citation>
        </ref>
        <ref id="article-101816.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hsu</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Gao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Meyers</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Broderick</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ding</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Peault</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Witwer</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>James</surname>
                <given-names>AW</given-names>
              </name>
            </person-group>
            <article-title>Human perivascular stem cell-derived extracellular vesicles mediate bone repair.</article-title>
            <source>Elife</source>
            <year>2019</year>
            <month>Sep</month>
            <day>04</day>
            <volume>8</volume>
            <pub-id pub-id-type="pmid">31482845</pub-id>
          </element-citation>
        </ref>
        <ref id="article-101816.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clines</surname>
                <given-names>GA</given-names>
              </name>
            </person-group>
            <article-title>Prospects for osteoprogenitor stem cells in fracture repair and osteoporosis.</article-title>
            <source>Curr Opin Organ Transplant</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>73</fpage>
            <page-range>73-8</page-range>
            <pub-id pub-id-type="pmid">19935065</pub-id>
          </element-citation>
        </ref>
        <ref id="article-101816.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ibrahim</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bulstrode</surname>
                <given-names>NW</given-names>
              </name>
              <name>
                <surname>Whitaker</surname>
                <given-names>IS</given-names>
              </name>
              <name>
                <surname>Eastwood</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Dunaway</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ferretti</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Nanotechnology for Stimulating Osteoprogenitor Differentiation.</article-title>
            <source>Open Orthop J</source>
            <year>2016</year>
            <volume>10</volume>
            <fpage>849</fpage>
            <page-range>849-861</page-range>
            <pub-id pub-id-type="pmid">28217210</pub-id>
          </element-citation>
        </ref>
        <ref id="article-101816.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lundberg</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Allison</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Baldock</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Brouard</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rost</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Enriquez</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Sainsbury</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lamghari</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Simmons</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Eisman</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Gardiner</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Herzog</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Greater bone formation of Y2 knockout mice is associated with increased osteoprogenitor numbers and altered Y1 receptor expression.</article-title>
            <source>J Biol Chem</source>
            <year>2007</year>
            <month>Jun</month>
            <day>29</day>
            <volume>282</volume>
            <issue>26</issue>
            <fpage>19082</fpage>
            <page-range>19082-91</page-range>
            <pub-id pub-id-type="pmid">17491022</pub-id>
          </element-citation>
        </ref>
        <ref id="article-101816.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Han</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mistry</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Cunningham</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Griffor</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bonnette</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Chrunyk</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Aspnes</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Brosius</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Buckbinder</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Structural characterization of proline-rich tyrosine kinase 2 (PYK2) reveals a unique (DFG-out) conformation and enables inhibitor design.</article-title>
            <source>J Biol Chem</source>
            <year>2009</year>
            <month>May</month>
            <day>08</day>
            <volume>284</volume>
            <issue>19</issue>
            <fpage>13193</fpage>
            <page-range>13193-201</page-range>
            <pub-id pub-id-type="pmid">19244237</pub-id>
          </element-citation>
        </ref>
        <ref id="article-101816.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nakamura</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yukita</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ninomiya</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hosoya</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hiraga</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ozawa</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Localization of Thy-1-positive cells in the perichondrium during endochondral ossification.</article-title>
            <source>J Histochem Cytochem</source>
            <year>2010</year>
            <month>May</month>
            <volume>58</volume>
            <issue>5</issue>
            <fpage>455</fpage>
            <page-range>455-62</page-range>
            <pub-id pub-id-type="pmid">20124093</pub-id>
          </element-citation>
        </ref>
        <ref id="article-101816.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jaqui&#x000e9;ry</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Schaeren</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Farhadi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mainil-Varlet</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kunz</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zeilhofer</surname>
                <given-names>HF</given-names>
              </name>
              <name>
                <surname>Heberer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>In vitro osteogenic differentiation and in vivo bone-forming capacity of human isogenic jaw periosteal cells and bone marrow stromal cells.</article-title>
            <source>Ann Surg</source>
            <year>2005</year>
            <month>Dec</month>
            <volume>242</volume>
            <issue>6</issue>
            <fpage>859</fpage>
            <page-range>859-67, discussion 867-8</page-range>
            <pub-id pub-id-type="pmid">16327496</pub-id>
          </element-citation>
        </ref>
        <ref id="article-101816.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dupree</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Pollack</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Laurencin</surname>
                <given-names>CT</given-names>
              </name>
            </person-group>
            <article-title>Fibroblast growth factor 2 induced proliferation in osteoblasts and bone marrow stromal cells: a whole cell model.</article-title>
            <source>Biophys J</source>
            <year>2006</year>
            <month>Oct</month>
            <day>15</day>
            <volume>91</volume>
            <issue>8</issue>
            <fpage>3097</fpage>
            <page-range>3097-112</page-range>
            <pub-id pub-id-type="pmid">16861274</pub-id>
          </element-citation>
        </ref>
        <ref id="article-101816.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>San Miguel</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Fatahi</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Igwe</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Aguila</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Kalajzic</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Defining a visual marker of osteoprogenitor cells within the periodontium.</article-title>
            <source>J Periodontal Res</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>45</volume>
            <issue>1</issue>
            <fpage>60</fpage>
            <page-range>60-70</page-range>
            <pub-id pub-id-type="pmid">19453851</pub-id>
          </element-citation>
        </ref>
        <ref id="article-101816.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dhouskar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tamgadge</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tamgadge</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Periera</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mudaliar</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Pillai</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Comparison of Hematoxylin and Eosin Stain with Modified Gallego's Stain for Differentiating Mineralized Components in Ossifying Fibroma, Cemento-ossifying Fibroma, and Cementifying Fibroma.</article-title>
            <source>J Microsc Ultrastruct</source>
            <year>2019</year>
            <season>Jul-Sep</season>
            <volume>7</volume>
            <issue>3</issue>
            <fpage>124</fpage>
            <page-range>124-129</page-range>
            <pub-id pub-id-type="pmid">31548923</pub-id>
          </element-citation>
        </ref>
        <ref id="article-101816.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roodman</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Windle</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Paget disease of bone.</article-title>
            <source>J Clin Invest</source>
            <year>2005</year>
            <month>Feb</month>
            <volume>115</volume>
            <issue>2</issue>
            <fpage>200</fpage>
            <page-range>200-8</page-range>
            <pub-id pub-id-type="pmid">15690073</pub-id>
          </element-citation>
        </ref>
        <ref id="article-101816.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sabharwal</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sepolia</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Panigrahi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mohanty</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Subudhi</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>An Insight in to Paget's Disease of Bone.</article-title>
            <source>Niger J Surg</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>9</fpage>
            <page-range>9-15</page-range>
            <pub-id pub-id-type="pmid">24665195</pub-id>
          </element-citation>
        </ref>
        <ref id="article-101816.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cortini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Baldini</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Avnet</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>New Advances in the Study of Bone Tumors: A Lesson From the 3D Environment.</article-title>
            <source>Front Physiol</source>
            <year>2019</year>
            <volume>10</volume>
            <fpage>814</fpage>
            <pub-id pub-id-type="pmid">31316395</pub-id>
          </element-citation>
        </ref>
        <ref id="article-101816.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Poon</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Guan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Nyan</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Van Vliet</surname>
                <given-names>KJ</given-names>
              </name>
            </person-group>
            <article-title>Bone marrow regeneration promoted by biophysically sorted osteoprogenitors from mesenchymal stromal cells.</article-title>
            <source>Stem Cells Transl Med</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>4</volume>
            <issue>1</issue>
            <fpage>56</fpage>
            <page-range>56-65</page-range>
            <pub-id pub-id-type="pmid">25411477</pub-id>
          </element-citation>
        </ref>
        <ref id="article-101816.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hutchings</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Moncrieff</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Dompe</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Janowicz</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sibiak</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bryja</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jankowski</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mozdziak</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bukowska</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Antosik</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Shibli</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Dyszkiewicz-Konwi&#x00144;ska</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bruska</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kempisty</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Piotrowska-Kempisty</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Bone Regeneration, Reconstruction and Use of Osteogenic Cells; from Basic Knowledge, Animal Models to Clinical Trials.</article-title>
            <source>J Clin Med</source>
            <year>2020</year>
            <month>Jan</month>
            <day>04</day>
            <volume>9</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">31947922</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
